[HTML][HTML] Therapeutics for COVID-19 and post COVID-19 complications: An update

D Basu, VP Chavda, AA Mehta - Current Research in Pharmacology and …, 2022 - Elsevier
Since its inception in late December 2020 in China, novel coronavirus has affected the
global socio-economic aspect. Currently, the world is seeking safe and effective treatment …

[HTML][HTML] Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

V Soriano, C De-Mendoza, B Edagwa, A Treviño… - AIDS …, 2022 - ncbi.nlm.nih.gov
Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-
threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against …

[HTML][HTML] Third wave of COVID-19 in Madrid, Spain

V Soriano, C de Mendoza, F Gómez-Gallego… - International Journal of …, 2021 - Elsevier
A third wave of COVID-19 occurred after Christmas 2020 in Madrid, one of the European
pandemic epicenters. We noticed 6 major differential features to previous waves. First …

Bacterial infections in patients hospitalized with COVID-19

V Moreno-Torres, C de Mendoza… - Internal and emergency …, 2022 - Springer
Bacterial infections may complicate the course of COVID-19 patients. The rate and
predictors of bacterial infections were examined in patients consecutively admitted with …

Analysis of all-cause hospitalization and death among nonhospitalized patients with type 2 diabetes and SARS-CoV-2 infection treated with molnupiravir or …

DTW Lui, MSH Chung, EHY Lau, KTK Lau… - JAMA network …, 2023 - jamanetwork.com
Importance Diabetes and COVID-19 are both global pandemics, and type 2 diabetes is a
common comorbidity in patients with acute COVID-19 and is proven to be a key determinant …

[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

Combination therapies for COVID‐19: An overview of the clinical trials landscape

S Akinbolade, D Coughlan, R Fairbairn… - British journal of …, 2022 - Wiley Online Library
The COVID‐19 pandemic has driven an unprecedented level of global activity in drug
discovery and clinical development for effective therapeutics targeting the coronavirus …

A prospective follow-up on thyroid function, thyroid autoimmunity and long COVID among 250 COVID-19 survivors

DTW Lui, KH Tsoi, CH Lee, CYY Cheung, CHY Fong… - Endocrine, 2023 - Springer
Purpose We evaluated the evolution of thyroid function and autoimmunity among COVID-19
survivors over 6 months in relation to interferon beta-1b treatment and long COVID. Methods …

[HTML][HTML] Influence of chronic use of corticosteroids and calcineurin inhibitors on COVID-19 clinical outcomes: analysis of a nationwide registry

J Calderón-Parra, V Cuervas-Mons… - International Journal of …, 2022 - Elsevier
Objectives The aim of this study was to analyze whether subgroups of immunosuppressive
(IS) medications conferred different outcomes in COVID-19. Methods The study involved a …

Post-COVID-19 anosmia and therapies: stay tuned for new drugs to sniff out

G Riccardi, GF Niccolini, MG Bellizzi, M Fiore, A Minni… - Diseases, 2023 - mdpi.com
Background: Anosmia is defined as the complete absence of olfactory function, which can
be caused by a variety of causes, with upper respiratory tract infections being among the …